InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (8 ops.)
Explore the detailed record of transactions filed by SIPAREX PROXIMITE INNOVATION SAS, Membre du Conseil. Officer active across 1 companies, notably ARCURE. Cumulatively, 13 reports have been recorded. Total volume traded: €122k. The latest transaction was disclosed on 26 May 2021 — Acquisition. Regulator: AMF. All data is free.
Declarations13 total
€25,2407,078 shares@ €3.5660.095% mcap20.8% of flow
ActionEuronext Growth Paris
2021DD757753·
Ideal exit: 20 Feb 2022 (T+270)
€17,6994,972 shares@ €3.55970.067% mcap14.6% of flow
ActionEuronext Growth Paris
2021DD747346·
Ideal exit: 13 Feb 2022 (T+270)
€3610 shares@ €3.600.0001% mcap0.0% of flow
ActionEuronext Growth Paris
2021DD747154·
€17,6994,972 shares@ €3.55970.067% mcap14.6% of flow
ActionEuronext Growth Paris
2021DD746853·
Ideal exit: 13 Feb 2022 (T+270)
€551153 shares@ €3.600.0021% mcap0.5% of flow
ActionEuronext Growth Paris
2021DD746037·
€552153 shares@ €3.6050.0021% mcap0.5% of flow
ActionEuronext Growth Paris
2021DD745121·
€6,4871,802 shares@ €3.600.025% mcap5.3% of flow
ActionEuronext Growth Paris
2021DD744170·
€19,9735,625 shares@ €3.55080.076% mcap16.4% of flow
ActionEuronext Growth Paris
2021DD743132·
Ideal exit: 23 Jan 2022 (T+270)
€12,9363,510 shares@ €3.68560.049% mcap10.6% of flow
ActionEuronext Growth Paris
2021DD742168·
Ideal exit: 16 Jan 2022 (T+270)
€1,101300 shares@ €3.670.0042% mcap0.9% of flow
ActionEuronext Growth Paris
2021DD741697·
€6,6551,828 shares@ €3.64060.025% mcap5.5% of flow
ActionEuronext Growth Paris
2021DD741600·
€5,3161,458 shares@ €3.64610.020% mcap4.4% of flow
ActionEuronext Growth Paris
2021DD740328·
€7,2622,000 shares@ €3.63120.027% mcap6.0% of flow
ActionEuronext Growth Paris
2021DD740129·
13 of 13 declarations
About SIPAREX PROXIMITE INNOVATION SAS
SIPAREX PROXIMITE INNOVATION SAS is a member of the supervisory board of ARCURE. In this role, it contributes to overseeing the company's activities and making strategic decisions. Its involvement is essential for ARCURE's development.
